资讯 | 苹果(AAPL)销量不及预期,股价大跌6.6%

wechat omage

美股

截至北京时间11月3日凌晨,美股周五收跌,苹果财报欠佳拖累科技股下滑。投资者仍在评估财报、非农就业数据与国际贸易关系等因素。

截止收盘,道指跌109.91点,或0.43%,报25,270.83点;标普500指数跌17.31点,或0.63%,报2,723.06点;纳指跌77.06点,或1.04%,报7,356.99点。

美股周五高开低走,道指震荡幅度达500点,盘中最高曾上涨198点,最低曾下跌逾300点。科技板块跌幅领先。苹果公司(AAPL)股价收跌6.6%,因其周四晚间公布的财报令人失望。

宏观基本面:

美国劳工部宣布,10月非农就业人数增加25万,远超预期,其中私营部门就业人数增加24.6万。报告显示,有更多的人加入劳动大军,失业率仍稳定在3.7%的49年低点,显示就业市场信心十足。

美国商务部公布数据显示,9月贸易逆差扩大至540亿美元,为连续第四个月扩大,预期逆差536亿美元。9月出口2126亿美元,较上月增加31亿美元;进口2666亿美元,较上月增加38亿美元。

焦点股关注:

苹果公司(AAPL)收跌6.6%。该公司第四财季营收为629.00亿美元,比去年同期的525.79亿美元增长20%,其中服务业务营收达100亿美元,创下历史纪录;净利润为141.25亿美元,比去年同期的107.14亿美元增长32%。其中,大中华区营收为114.11亿美元,比去年同期的98.01亿美元增长16%。

苹果第四财季每股收益2.91美元,高于预期的2.78美元;营业收入629亿美元,高于预期的614.4亿美元;但iPhone销量4690万部,低于分析师预期的4840万部。此外,第四财季iPad销量970万。第四财季Mac销量530万。

阿里巴巴(BABA)收跌2.4%。该公司宣布第二财季营收851.48亿元,同比增长54%。按美国通用会计准则计算的盈利为234.53亿元,而去年同期Non-GAAP下净利润为220.89亿元,同比增长6.18%。

特斯拉(TSLA)收高0.6%。据报道,美国证券交易委员会与美国司法部正在调查该公司的Model 3生产计划是否误导了投资者。

 

   

港股

北京时间11月2日,香港恒生指数周五高开高走,收盘飙升上千点,涨幅达到4.21%,收报26486.35点,创近7年来最大单日涨幅;蓝筹股全线上涨,腾讯控股大涨逾9%。

上周五航空类个股热度高涨,三大行集体涨超10%,这凸显了汇率强势反弹的威力。同时受益的造纸类也表现不错。

医药类个股表现强劲,药明生物(2269)涨11.67%、中国生物制药(1177)涨10.98%、复星医药(2196)涨9.36%、三生制药(01530)涨9.23%

 

 

中国A股

北京时间11月2日,周五早盘三大股指集体高开,之后整体维持高位盘整,午后银行、保险、白马再度发力,题材概念也持续拉升,三大股指集体拉升,两市做多氛围高涨,市场总体普涨,各大板块全线飘红。

截止收盘,沪指报2676.48点,涨幅2.7%;深成指报7867.54点,涨幅3.96%。

从盘面上看,国家安防、航空机场、白酒、社保重仓、医疗服务等板块领涨两市。

热点板块:

上周五全天国家安防板块持续活跃,截止收盘,大华股份(002236)、海康威视(002415)等股票涨停,海能达(002583)、麦达数字(002137)等个股纷纷跟涨。

受人民币汇率大幅反弹影响,上周五航空股全线上扬,截止收盘,华夏航空(002928)涨停,吉祥航空(603885)、东方航空(600115)、上海机场(600009)、白云机场(600004)、南方航空(600029)等个股涨幅居前。

如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com